Akremi Najoua, Cappoen Davie, Anthonissen Roel, Bouraoui Abderrahman, Verschaeve Luc
Faculté de Pharmacie, Université de Monastir, Monastir, Tunisia.
Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.
Pharmacogn Mag. 2016 Jul;12(Suppl 4):S395-S399. doi: 10.4103/0973-1296.188318.
, a species of Mediterranean brown algae, is believed to have potential pharmacological and nutritional applications. However, such potentials only make sense when devoid of any adverse health consequences. The present study should be seen in this context. It aimed at evaluating the genotoxicity and cytoxicity of its organic extract (F) and semi purified fractions (F, F, and F). Extracts were tested using the bacterial Vitotox test and micronucleus assay in different concentrations (from 1.25 μg/mL up to 100 μg/mL, depending on the test and the extract). Applied concentrations were based on a preliminary dose-finding test with the neutral red uptake assay. The results show that all extracts were not genotoxic in the presence or absence of a rat metabolic enzyme fraction (S9). This is encouraging and justifies further investigations on the therapeutic and other values of this algae.
extracts and some of their semi purified fractions have important antibacterial properties.The organic extract (F) and semi purified fractions (F, F, and F) were not genotoxic according to the bacterial Vitotox test.They were also not genotoxic according to the micronucleus test in human C3A cells.Applied concentrations were based on the neutral red uptake (NRU) test.
,一种地中海褐藻,被认为具有潜在的药理和营养应用。然而,只有在没有任何不良健康后果的情况下,这些潜力才有意义。本研究应在此背景下看待。其目的是评估其有机提取物(F)和半纯化组分(F、F和F)的遗传毒性和细胞毒性。提取物在不同浓度(根据测试和提取物,从1.25μg/mL到100μg/mL)下使用细菌维托克斯试验和微核试验进行测试。应用浓度基于用中性红摄取试验进行的初步剂量探索试验。结果表明,在有或没有大鼠代谢酶组分(S9)的情况下,所有提取物均无遗传毒性。这令人鼓舞,并证明有必要进一步研究这种藻类的治疗价值和其他价值。
提取物及其一些半纯化组分具有重要的抗菌特性。根据细菌维托克斯试验,有机提取物(F)和半纯化组分(F、F和F)无遗传毒性。根据人C3A细胞中的微核试验,它们也无遗传毒性。应用浓度基于中性红摄取(NRU)试验。